Comparison of Clinical Outcomes Between Low- and High-Risk Groups of Early Breast Cancer Patients Treated with Intraoperative Radiotherapy in Addition to External Beam Radiation: A Multi-Centre Prospective Study

[1]  Xin-xin Chen,et al.  Impact of intraoperative radiotherapy on the perioperative period of patients after breast-conserving surgery. , 2020, Gland surgery.

[2]  C. Nantavithya,et al.  Results of intraoperative radiotherapy given as a boost after breast conserving-surgery. , 2020, Gland surgery.

[3]  Guowen Li,et al.  Efficacy analysis of intraoperative radiotherapy in patients with early-stage breast cancer , 2020, Cancer Cell International.

[4]  U. Güth,et al.  Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective , 2020, Breast Cancer.

[5]  Ana Alicia Tejera Hernández,et al.  Complications and local relapse after intraoperative low-voltage X-ray radiotherapy in breast cancer , 2020, Annals of surgical treatment and research.

[6]  G. Viani,et al.  Partial-breast irradiation versus whole-breast radiotherapy for early breast cancer: A systematic review and update meta-analysis. , 2020, Brachytherapy.

[7]  S. Rana,et al.  Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program. , 2020, American journal of surgery.

[8]  C. Shah,et al.  Outcomes with intraoperative radiation therapy for early‐stage breast cancer , 2020, The breast journal.

[9]  F. Wang,et al.  Efficacy, late complications, and cosmetic outcomes of targeted intraoperative radiotherapy in breast-conserving surgery for early-stage breast cancer: a single-centre study in China. , 2019, Japanese journal of clinical oncology.

[10]  R. Yerushalmi,et al.  Intraoperative radiation therapy for breast cancer—Immediate and 30‐month oncological outcomes , 2019, The breast journal.

[11]  A. Stanisławek,et al.  Satisfaction with the Aesthetic Effect and Quality of Life for Women after Breast Conserving Therapy (BCT)—Preliminary Research , 2019, International journal of environmental research and public health.

[12]  F. Wenz,et al.  Long-term outcome after intraoperative radiotherapy as a boost in breast cancer , 2019, Strahlentherapie und Onkologie.

[13]  A. Ringberg,et al.  Aesthetic outcome following breast‐conserving surgery assessed by three evaluation modalities in relation to health‐related quality of life , 2018, The British journal of surgery.

[14]  Joon Jeong,et al.  A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients , 2018, Breast Cancer Research and Treatment.

[15]  S. Racadot,et al.  Up to 5 years outcomes following intraoperative radiotherapy for early breast cancer , 2018, Translational Cancer Research.

[16]  S. Key,et al.  Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam® Device: A Prospective Study , 2017, Annals of Surgical Oncology.

[17]  A. Ringberg,et al.  Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™ , 2017, Breast Cancer Research and Treatment.

[18]  N. deSouza,et al.  Initial experience of the BREAST-Q breast-conserving therapy module , 2016, Breast Cancer Research and Treatment.

[19]  M. Baum,et al.  Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial. , 2016, International journal of radiation oncology, biology, physics.

[20]  B. Rosen,et al.  TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer , 2016, Annals of Surgical Oncology.

[21]  L. Esserman,et al.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial , 2014, The Lancet.

[22]  A. Luini,et al.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. , 2013, The Lancet. Oncology.

[23]  Joanne S Haviland,et al.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. , 2013, The Lancet. Oncology.

[24]  M. Baum,et al.  Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. , 2011, International journal of radiation oncology, biology, physics.

[25]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[26]  Y. Juliano,et al.  Evaluations of aesthetic outcomes of oncoplastic surgery by surgeons of different gender and specialty: a prospective controlled study. , 2011, Breast.

[27]  L. Esserman,et al.  Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial , 2010, The Lancet.

[28]  B. Haffty,et al.  Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer , 2010 .

[29]  F. Lovat,et al.  Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding , 2008, Clinical Cancer Research.

[30]  Constance M. Chen,et al.  Measuring Quality of Life in Cosmetic and Reconstructive Breast Surgery: A Systematic Review of Patient-Reported Outcomes Instruments , 2007, Plastic and reconstructive surgery.

[31]  Lawrence B Marks,et al.  Definition of postlumpectomy tumor bed for radiotherapy boost field planning: CT versus surgical clips. , 2005, International journal of radiation oncology, biology, physics.

[32]  S. Tribius,et al.  Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. , 2003, International journal of radiation oncology, biology, physics.

[33]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[34]  E Marubini,et al.  Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  D. Altman,et al.  Statistics notes: Cronbach's alpha , 1997 .

[36]  J. Lowery,et al.  Evaluations of Aesthetic Results in Breast Reconstruction: An Analysis of Reliability , 1996, Annals of plastic surgery.

[37]  A S Lichter,et al.  Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  C. Redmond,et al.  Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer , 1989 .

[39]  A. Luini,et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. , 1982, The New England journal of medicine.